1cBio Email Formats

Biotechnology Research • San Francisco, California, United States • 1-10 Employees

1cBio Email Formats

1cBio uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@1cbio.com), used 66.7% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@1cbio.com	66.7%
{first name}.{last name}	john.doe@1cbio.com	33.3%

Key Contact at 1cBio

Son Pham

Co-Founder And Vice President, Chemistry

Company overview

Headquarters	San Francisco, California, United States
Website	1cbio.com
NAICS	541714
Keywords	Oncology, Rare Disease, HPP
Founded	2022
Employees	1-10

About 1cBio

1cBio is an emerging biotech company based in the San Francisco Bay Area developing precision medicines for significant unmet needs. We focus on defined mechanisms of action which are validated in clinical practice, clinical trials, or preclinical models. Typically, our programs are geared to treat the disease and preemptively counter mechanisms for acquired or intrinsic resistance. We combine our core expertise in medicinal chemistry and translational sciences with thought partners in clinical and basic sciences to guide our innovation. Together with our network of research and development partners, our discovery platform is rapidly scalable and easily tailored to suit our current and future needs. Our most advanced programs are a potential first-in-class oral small molecule inhibitor for a novel target to treat hypophosphatasia (HPP) and a potential best-in-class selective PARP1 inhibitor. Both programs have started IND-supporting preclinical studies. PARP1 is the first program from our emerging portfolio of DDR-related programs which target both HR deficient and HR proficient tumors, in breast, prostate, ovarian and pancreatic cancers.